Active	Status	Sponsor type	Region	Phase	Filter
7 Active 1 Inactive 8 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

7 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Mattingly, Gregory
KP415P01, NCT05685732: An Efficacy and Safety Study w/ Azstarys® in Children With ADHD	Active, not recruiting	4	246	US	Serdexmethylphenidate (SDX) and dexmethylphenidate (d-MPH), placebo	Corium, Inc., Premier Research Group plc, Prometrika, LLC, Almac	Attention Deficit/Hyperactivity Disorder	05/24	06/24
KP415P02, NCT05721235: A Safety/Tolerability and PK Study With Azstarys® in Children With ADHD	Recruiting	4	100	US	Serdexmethylphenidate (SDX) and dexmethylphenidate (d-MPH)	Corium, Inc., Premier Research Group plc, Prometrika, LLC, Almac, Worldwide Clinical Trials	Attention Deficit/Hyperactivity Disorder	03/25	03/25
D1AMOND, NCT05615220: Ecopipam Tablets to Study Tourette's Disorder in Children, Adolescents and Adults	Recruiting	3	196	Europe, Canada, US, RoW	Ecopipam Hydrochloride	Emalex Biosciences Inc.	Tourette Disorder	12/24	12/24
NCT05169710 / 2021-002126-24: A Clinical Study of an Investigational Drug for the Treatment of Major Depressive Episode Associated With Bipolar I Disorder.	Terminated	3	83	Europe, Canada, Japan, US	SEP-4199 CR 200 mg, SEP-4199 CR 400 mg, Placebo	Sumitomo Pharma America, Inc., Sunovion Pharmaceuticals Inc.	Depressive Episodes, Bipolar I Depression	10/23	10/23
BVR-100-102, NCT06037668: A Randomized, Controlled Study of Two At-Home Self-Guided Virtual Reality Interventions for Adults With Social Anxiety Disorder.	Completed	N/A	56	US	BVR-100, BES-100	Sumitomo Pharma America, Inc., BehaVR LLC	Social Anxiety Disorder (SAD)	12/23	01/24
Mattingly, Greg
A-GAMES, NCT05805176: An Adjunct Study to Assess Guided ADHD Therapy for Managing the Extent and Severity of Symptoms	Recruiting	N/A	194	US	ADHD Therapy	Lumos Labs, Inc.	ADHD	03/25	06/25
Batterson, James R
D1AMOND, NCT05615220: Ecopipam Tablets to Study Tourette's Disorder in Children, Adolescents and Adults	Recruiting	3	196	Europe, Canada, US, RoW	Ecopipam Hydrochloride	Emalex Biosciences Inc.	Tourette Disorder	12/24	12/24
Meyer, Julie
No trials found
Greg, Mattingly R
No trials found